7LU9 image
Deposition Date 2021-02-21
Release Date 2021-03-24
Last Version Date 2024-10-23
Entry Detail
PDB ID:
7LU9
Title:
Cryo-EM structure of DH851.3 bound to HIV-1 CH505 Env
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
5.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp41
Chain IDs:M (auth: a), O (auth: b), Q (auth: c)
Chain Length:153
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp120
Gene (Uniprot):env
Chain IDs:N (auth: d), P (auth: e), R (auth: f)
Chain Length:461
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:DH851.3 light chain
Chain IDs:A (auth: k), H (auth: j), L (auth: r)
Chain Length:210
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:DH851.3 heavy chain
Chain IDs:B (auth: l), G (auth: i), K (auth: q)
Chain Length:228
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:DH851.3 heavy chain
Chain IDs:C (auth: m), F (auth: h), J (auth: p)
Chain Length:222
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:DH851.3 light chain
Chain IDs:D (auth: n), E (auth: g), I (auth: o)
Chain Length:207
Number of Molecules:3
Biological Source:Macaca mulatta
Ligand Molecules
Primary Citation

Abstact

Natural antibodies (Abs) can target host glycans on the surface of pathogens. We studied the evolution of glycan-reactive B cells of rhesus macaques and humans using glycosylated HIV-1 envelope (Env) as a model antigen. 2G12 is a broadly neutralizing Ab (bnAb) that targets a conserved glycan patch on Env of geographically diverse HIV-1 strains using a unique heavy-chain (VH) domain-swapped architecture that results in fragment antigen-binding (Fab) dimerization. Here, we describe HIV-1 Env Fab-dimerized glycan (FDG)-reactive bnAbs without VH-swapped domains from simian-human immunodeficiency virus (SHIV)-infected macaques. FDG Abs also recognized cell-surface glycans on diverse pathogens, including yeast and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike. FDG precursors were expanded by glycan-bearing immunogens in macaques and were abundant in HIV-1-naive humans. Moreover, FDG precursors were predominately mutated IgM+IgD+CD27+, thus suggesting that they originated from a pool of antigen-experienced IgM+ or marginal zone B cells.

Legend

Protein

Chemical

Disease

Primary Citation of related structures